← Back to headlines
Teva (TEVA) Finalizes New $700 Million Acquisition Deal
Teva Pharmaceutical Industries has announced a new acquisition deal valued at $700 million. This strategic move is expected to expand the company's portfolio and market presence.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
